Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/1995
08/10/1995WO1995021248A1 Method for using tobacco mosaic virus to overproduce peptides and proteins
08/10/1995WO1995021247A1 The use of an alpha-amylase modified to improve oxidation stability in a combined desizing and bleaching process
08/10/1995WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/10/1995WO1995021244A1 Monoclonal antibody 88bv59, subclones and method of making
08/10/1995WO1995021197A1 Il-3 variant hematopoiesis fusion protein
08/10/1995WO1995021195A1 Non-viral vector
08/10/1995WO1995021189A1 Hepatitis b vaccine
08/10/1995WO1995021188A1 Subunits of glutamate receptors, method for producing them and their use
08/10/1995WO1995021184A1 Substituted purines and oligonucleotide cross-linking
08/10/1995WO1995021179A1 Endotoxin reduction or removal process
08/10/1995WO1995021178A1 Nucleic acid transfection efficiency increase by use of isopropanol in aqueous solutions
08/10/1995WO1995021177A1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
08/10/1995WO1995020977A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
08/10/1995WO1995020976A1 Co-administration of interleukin-3 mutants with colony stimulating factors
08/10/1995WO1995020974A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/10/1995WO1995020872A1 Genetic engineering of mollusks
08/10/1995WO1995018830A3 Inhibitors of human plasmin derived from the kunitz domains
08/10/1995WO1995015373A3 Inhibition of dna methyltransferase
08/10/1995WO1995001442A3 Nucleotide and amino acid sequences of the envelope 1 gene of 51 hepatitis c virus isolates and the use of reagents derived therefrom as diagnostic reagents and vaccines
08/10/1995DE4403666A1 Untereinheiten von Glutamatrezeptoren, Verfahren zu ihrer Herstellung und ihre Verwendung Subunits of glutamate receptors, methods for their preparation and their use
08/10/1995CA2182708A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof
08/10/1995CA2182685A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995CA2182618A1 Subunits of glutamate receptors, method for producing them and their use
08/10/1995CA2182616A1 Non-viral vector
08/10/1995CA2182501A1 Genetic engineering of mollusks
08/10/1995CA2182498A1 Fusion proteins that include antibody and nonantibody portions
08/10/1995CA2182484A1 Multivariant il-3 hematopoiesis fusion protein
08/10/1995CA2182474A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
08/10/1995CA2182473A1 Co-administration of interleukin-3 mutants with colony stimulating factors
08/10/1995CA2182375A1 Hepatitis b vaccine
08/10/1995CA2182369A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/10/1995CA2182299A1 Wd-40-derived peptides and uses thereof
08/10/1995CA2159217A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/10/1995CA2158572A1 Monoclonal antibody 88bv59, subclones and method of making
08/09/1995EP0666318A1 Enzyme participating in c-terminal amidation, and method of preparing same and use thereof
08/09/1995EP0666317A2 Antisense oligonucleotides against HSV-1 and their preparation
08/09/1995EP0666316A2 Method for obtaining organic solvent-resistant microorganisms and organic solvent-resistant microorganisms obtainable by the method
08/09/1995EP0666314A1 Cloning by complementation and related processes
08/09/1995EP0666313A2 Targeting of telomerase in cancer gene therapy
08/09/1995EP0665898A1 Angiotensinogen gene variants and predisposition to hypertension
08/09/1995EP0665892A1 Enhanced indole biosynthesis
08/09/1995EP0665891A1 Genetic moderation or restoration of plant phenotypes
08/09/1995EP0665890A1 Increased production of secreted proteins by recombinant eukaryotic cells
08/09/1995EP0665889A1 Enzymes with a nitrile-hydratase activity, genetic tools and host micro-organisms for their production and method of hydrolysis using said enzymes
08/09/1995EP0665888A1 Ryegrass pollen allergen
08/09/1995EP0665887A1 Human 5-ht 2? receptor
08/09/1995EP0665886A1 Cyclin complex rearrangement and uses related thereto
08/09/1995EP0665885A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof
08/09/1995EP0665884A1 Protein partner screening assays and uses thereof
08/09/1995EP0665883A1 Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals
08/09/1995EP0665882A1 Dna compounds comprising sequences encoding mannuronan c-5-epimerase
08/09/1995EP0665852A1 Recombinant ctla4 polypeptides and methods for making the same
08/09/1995EP0665739A1 Morphogen-induced periodontal tissue regeneration
08/09/1995EP0535007B1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS
08/09/1995EP0490972B1 Recombinant negative strand rna virus expression systems and vaccines
08/09/1995EP0403631B1 Method of making high density solder bumps and a substrate socket for high density solder bumps
08/09/1995CN1106459A Fractionation method for nucleotide fragments
08/09/1995CN1106456A A recombinant 9 desaturase and a gene encoding the same
08/08/1995US5440028 Process for preparing purified glycolipids by membrane separation processes
08/08/1995US5440025 Process for separating nucleic acid polymers
08/08/1995US5440018 Ultrfiltration, acidd treating, ion exchanging, purifying
08/08/1995US5440017 T-cell lymphoma cDNA clones
08/08/1995US5439886 Monoclonal antibody, polypeptides and production thereof
08/08/1995US5439829 Bonding chelating agent to biologically active molecule on a support, treating with oxidizing or reducing agent to change oxidation state of chelating metal ion and immobilize active molecule on the support
08/08/1995US5439824 Increased expression of α-1-antitrypsin in expression vectors through the inclusion of intron II
08/08/1995US5439822 Gene expression regulatory DNA
08/08/1995US5439821 A biosynthesized pentapeptides is used as insecticides, antifertility agent of mosquitoes
08/08/1995US5439820 Anti-thrombin polypeptides
08/08/1995US5439818 Wound healing agents
08/08/1995US5439815 Restrictocin-like ribotoxin analogues comprising only one cysteine available for covalent linkage to a partner
08/08/1995US5439814 Inserting DNA into plasmid, genetic transcription of DNA into RNA, transfection of cells, recovering rubella for vaccines
08/08/1995US5439811 Reacting RNA with l-tyrosine or l-phenylalanine in the presence of an aminoacyl RNA hydrolase
08/08/1995US5439810 Manipulation of gene copy number in bordetella
08/08/1995US5439809 Non-infectious HIV particles lacking long terminal repeats
08/08/1995US5439808 Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
08/08/1995US5439807 Methods for the preparation of endotoxin-binding proteins
08/08/1995US5439795 Cystine residue linked to glycine residue at the end of carboxy terminus of peptide; animal growth regulator
08/08/1995US5439679 Peptide plasminogen activators
08/05/1995CA2141907A1 Virus msrvl and pathogen agent and/or msrv2 associated with multiple sclerosis, their nucleic constituants and their applications
08/03/1995WO1995020682A1 Methods for the elimination of dna sequencing artifacts
08/03/1995WO1995020681A1 Comparative gene transcript analysis
08/03/1995WO1995020678A1 Human dna mismatch repair proteins
08/03/1995WO1995020672A1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies
08/03/1995WO1995020671A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof
08/03/1995WO1995020670A1 Cd 69 transcriptional regulatory elements
08/03/1995WO1995020669A2 Soybean cyst nematode resistant soybeans and methods of breeding and identifying resistant plants
08/03/1995WO1995020668A1 Methods for the production of modified plants
08/03/1995WO1995020666A2 Transgenic non-human mammals with progressive neurologic disease
08/03/1995WO1995020665A1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters
08/03/1995WO1995020664A2 Mammalian expression systems for hepatitis c virus envelope genes
08/03/1995WO1995020663A2 THERMOSTABLE VARIANTS OF NEUTRAL PROTEASES OF BACILLUS STEAROTHERMOPHILUS AND $i(BACILLUS THERMOPROTEOLYTICUS)
08/03/1995WO1995020662A1 Transglutaminase originating in japanese oyster
08/03/1995WO1995020661A1 Materials and methods for management of hyperacute rejection in human xenotransplantation
08/03/1995WO1995020660A2 Immunization by inoculation of dna transcription unit
08/03/1995WO1995020659A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM
08/03/1995WO1995020658A2 Diagnosis and treatment of infections due to streptococci and enterococci
08/03/1995WO1995020657A1 Receptor specific bacterial adhesins and their use
08/03/1995WO1995020656A1 Diagnosis of metastatic cancer by the mts-1 gene
08/03/1995WO1995020655A1 Novel cell surface receptor, antibody compositions, and methods of using same
08/03/1995WO1995020654A1 Folding proteins
1 ... 3750 3751 3752 3753 3754 3755 3756 3757 3758 3759 3760 3761 3762 3763 3764 3765 3766 3767 3768 3769 3770 ... 4023